Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Bone Marrow Stem Cells for Ischemic Retinopathy
NCT01518842Phase 2Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Sep 2011
- Primary completion
- Oct 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell in ischemic retinopathy, sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
ischemic retinopathy
Beyond the preview
Go deeper on NCT01518842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518842.